| Sarah Nasreen Saeed, MD | |
|
530 Ne Glen Oak Ave, Peoria, IL 61637-0001 | |
| (309) 655-6384 | |
| (309) 655-7732 |
| Full Name | Sarah Nasreen Saeed |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 8 Years |
| Location | 530 Ne Glen Oak Ave, Peoria, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639606411 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 036159912 (Illinois) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint James Hospital | Pontiac, IL | Hospital |
| Ottawa Regional Hospital Dba Osf Saint Elizabeth Mdl Ctr | Ottawa, IL | Hospital |
| St Bernard Hospital | Chicago, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Osf Multi-specialty Group | 3678889789 | 1543 |
News Archive
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that patient screening in its DSC127 Phase 2 trial in diabetic foot ulcer healing will be completed tomorrow, and that enrollment in the trial will conclude on September 30. This randomized, double-blind, placebo controlled study of up to 75 patients will look at the percentage of diabetic ulcers completely healed over a 12-week period, among other outcomes.
"President Obama and leading Democrats have stressed that people who like their employer-sponsored insurance would be able to keep it, under a health care overhaul. But they haven't emphasized the flip side: That people who don't like their coverage might have to keep it," Kaiser Health News reports.
ElMindA Ltd. announced today that the United States Food and Drug Administration has cleared the company's BNA Analysis System for the assessment of brain function. Brain Network Activity (BNA) combines non-invasive, multi-channel EEG technology with sophisticated signal processing and analysis algorithms to measure patterns of brain networks activated during specific brain processes and deliver both quantitative and qualitative insights into brain functionality.
By exploiting an HIV protein that readily traverses cell membranes, Carnegie Mellon University scientists have developed a new way to introduce a gene-like molecule called a peptide nucleic acid (PNA) directly into live mammalian cells, including human embryonic stem (ES) cells.
› Verified 5 days ago
| Entity Name | Osf Multi-specialty Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922445527 PECOS PAC ID: 3678889789 Enrollment ID: O20150904000279 |
News Archive
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that patient screening in its DSC127 Phase 2 trial in diabetic foot ulcer healing will be completed tomorrow, and that enrollment in the trial will conclude on September 30. This randomized, double-blind, placebo controlled study of up to 75 patients will look at the percentage of diabetic ulcers completely healed over a 12-week period, among other outcomes.
"President Obama and leading Democrats have stressed that people who like their employer-sponsored insurance would be able to keep it, under a health care overhaul. But they haven't emphasized the flip side: That people who don't like their coverage might have to keep it," Kaiser Health News reports.
ElMindA Ltd. announced today that the United States Food and Drug Administration has cleared the company's BNA Analysis System for the assessment of brain function. Brain Network Activity (BNA) combines non-invasive, multi-channel EEG technology with sophisticated signal processing and analysis algorithms to measure patterns of brain networks activated during specific brain processes and deliver both quantitative and qualitative insights into brain functionality.
By exploiting an HIV protein that readily traverses cell membranes, Carnegie Mellon University scientists have developed a new way to introduce a gene-like molecule called a peptide nucleic acid (PNA) directly into live mammalian cells, including human embryonic stem (ES) cells.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Nasreen Saeed, MD 221 Forest Trl, Oak Brook, IL 60523-1412 Ph: (630) 269-5579 | Sarah Nasreen Saeed, MD 530 Ne Glen Oak Ave, Peoria, IL 61637-0001 Ph: (309) 655-6384 |
News Archive
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that patient screening in its DSC127 Phase 2 trial in diabetic foot ulcer healing will be completed tomorrow, and that enrollment in the trial will conclude on September 30. This randomized, double-blind, placebo controlled study of up to 75 patients will look at the percentage of diabetic ulcers completely healed over a 12-week period, among other outcomes.
"President Obama and leading Democrats have stressed that people who like their employer-sponsored insurance would be able to keep it, under a health care overhaul. But they haven't emphasized the flip side: That people who don't like their coverage might have to keep it," Kaiser Health News reports.
ElMindA Ltd. announced today that the United States Food and Drug Administration has cleared the company's BNA Analysis System for the assessment of brain function. Brain Network Activity (BNA) combines non-invasive, multi-channel EEG technology with sophisticated signal processing and analysis algorithms to measure patterns of brain networks activated during specific brain processes and deliver both quantitative and qualitative insights into brain functionality.
By exploiting an HIV protein that readily traverses cell membranes, Carnegie Mellon University scientists have developed a new way to introduce a gene-like molecule called a peptide nucleic acid (PNA) directly into live mammalian cells, including human embryonic stem (ES) cells.
› Verified 5 days ago
Sandeep Banga, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 530 Ne Glen Oak Ave, Peoria, IL 61637 Phone: 309-655-6384 Fax: 309-655-7732 | |
Riaz Shah, MD Rheumatology Medicare: May Accept Medicare Assignments Practice Location: 221 Ne Glen Oak Ave, Suite 504, Peoria, IL 61636 Phone: 309-672-5729 | |
Dr. James Daniel Dewar, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 530 Ne Glen Oak Ave, Peoria, IL 61637 Phone: 309-655-7257 | |
Waqas Ali, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 221 Ne Glen Oak Ave, Peoria, IL 61636 Phone: 309-672-5522 | |
Dr. Sudhir Mungee, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5405 North Knoxville Avenue, Peoria, IL 61614 Phone: 309-691-4410 Fax: 309-589-2830 | |
Dr. Nikesh Kavi Patel, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 530 Ne Glen Oak Ave, Peoria, IL 61637 Phone: 309-655-6384 Fax: 309-655-7732 | |
Dr. Bhanu T Paturi, M.D Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5105 N Glen Park Place Rd, Peoria, IL 61614 Phone: 309-683-8383 |